Reported zero revenue for the three and six months ended November 30, 2025. Net loss for the six-month period was $857,028, compared to $18,293 in the prior year period. Operating expenses increased significantly to $688,189 for the six months, driven by management costs and R&D. Cash balance as of November 30, 2025, was $13,846. Working capital deficit improved to $754,919 from $2,341,169 as of May 31, 2025, largely due to debt conversions. Company is in the development stage for health care payment and personal financial management products.